Home » Topics » Cardiovascular, BioWorld Science

Cardiovascular, BioWorld Science
RSS

GlycoMimetics synthesizes new LGALS3 inhibitors

July 21, 2020

NIH grant supports development of Vivasc's CTP-amio for arrhythmia

July 17, 2020

New phase II study evaluates RUC-4 in patients with STEMI

July 9, 2020

Noncoding mutations contribute to heart disease

July 8, 2020

TN1-006: a gene therapy-mediated cardiac reprogramming candidate with potential for MI treatment

July 2, 2020

Antag Therapeutics describes new gastric inhibitory polypeptide receptor antagonists

July 1, 2020

Onoact approved for additional indication of tachyarrhythmia associated with sepsis in Japan

June 30, 2020

Topline results presented from phase I/II study of ITI-214 heart failure

June 30, 2020

Korea Research Institute of Chemical Technology patents PDE9A inhibitors

June 30, 2020

Positive data from phase III RHAPSODY study of rilonacept in recurrent pericarditis

June 30, 2020

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for June 10, 2026.
News in brief
BioWorld Asia
BioWorld Asia briefs for June 9, 2026
Skape Bio unlocks GPCR targets with de novo-designed miniproteins
BioWorld
Modulating G protein-coupled receptors (GPCRs) is one of the major challenges in biomedicine. These are flexible proteins with small, deep binding pockets. The...
Antares Therapeutics divulges new CDK2/cyclin E1 inhibitors
BioWorld Science
Antares Therapeutics Inc. has reported new CDK2/cyclin E1 inhibitors potentially useful for the treatment of cancer.
Empire Discovery Institute, Univ. of Rochester identify IRAK inhibitors
BioWorld Science
Empire Discovery Institute and the University of Rochester have discovered new interleukin-1 receptor-associated kinase 1 (IRAK-1) and/or IRAK-4 inhibitors...